Literature DB >> 4886242

A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics.

L E Hollister, J Shelton, G Krieger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4886242     DOI： 10.1176/ajp.125.10.1352

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  11 in total

Review 1.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

2.  Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

Authors:  Albert Garcia-Romeu; Roland R Griffiths; Matthew W Johnson
Journal:  Curr Drug Abuse Rev       Date:  2014

Review 3.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

Review 4.  Potential Therapeutic Effects of Psilocybin.

Authors:  Matthew W Johnson; Roland R Griffiths
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

Authors:  Matthew W Johnson; Albert Garcia-Romeu; Mary P Cosimano; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2014-09-11       Impact factor: 4.153

6.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-01       Impact factor: 4.530

Review 7.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 8.  The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.

Authors:  Clinton E Canal; Kevin S Murnane
Journal:  J Psychopharmacol       Date:  2016-11-15       Impact factor: 4.153

9.  Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.

Authors:  Michael P Bogenschutz; Samantha K Podrebarac; Jessie H Duane; Sean S Amegadzie; Tara C Malone; Lindsey T Owens; Stephen Ross; Sarah E Mennenga
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

10.  Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.

Authors:  Tara C Malone; Sarah E Mennenga; Jeffrey Guss; Samantha K Podrebarac; Lindsey T Owens; Anthony P Bossis; Alexander B Belser; Gabrielle Agin-Liebes; Michael P Bogenschutz; Stephen Ross
Journal:  Front Pharmacol       Date:  2018-04-03       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.